Javier Dotor PhD, Scientific Director of the company, has focused his professional career in biomedical research, with strong background both in basic research and preclinical development. He has more than 9 years of experience in preclinical development in Biotech SME (Digna Biotech, Natac Pharma and Azurebio), providing scientific solutions, support and management in relation to preclinical and other scientific aspects of drug development (analytics, formulation, toxicology and phase I/II clinical trials). He has worked mainly as preclinical responsible generating, as consequence of this activity, more than 40 PubMed indexed scientific publications and 8 international patents. Expertise in antifibrotic, immunomodulatory and antitumoral compounds activity, tuning several cell based assays as well as in vivo proofs of concept in different areas and multiple animal models.
Javier is our Scientific Director, PhD, Basic research and preclinical development expert in inflammation & immunology, author of 9 international patents. One of the few in Spain that developed a compound from lab discovery to advanced clinical research.
+34 912 187 043